Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation

---

Copy For Citation

ORAN İ., ÇINAR C., BOZKAYA H., KORKMAZ M.

JOURNAL OF NEUROINTERVENTIONAL SURGERY, vol.7, no.5, pp.357-362, 2015 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 7 Issue: 5
• Publication Date: 2015
• Doi Number: 10.1136/neurintsurg-2013-011023
• Journal Name: JOURNAL OF NEUROINTERVENTIONAL SURGERY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.357-362
• Kütahya Health Sciences University Affiliated: No

Abstract

Background and purpose Pretreatment with dual antiaggregant drugs is accepted as a standard step in intracranial stent implantation. The aim of this study was to determine whether tailored antiaggregant medication based on platelet reactivity testing with multiple electrode aggregometry (Multiplate) yields superior outcomes after intracranial flow-diverting stent (FDS) implantation compared with standard clopidogrel treatment.